Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Underwriters are also getting better at detecting GLP-1 use through: Prescription databases Medical records requests Follow-up health questionnaires What This Means for Your Clients If currently on GLP-1 medications: Expect questions about medication use and duration Be prepared for potentially higher rates despite current health improvements Consider timing of application if they've been stable on medication for an extended period If recently stopped GLP-1 medications: Underwriters may view recent discontinuation as a risk factor Weight regain could further complicate the application process Medical follow-up showing sustained health improvements may help If planning to start GLP-1 medications: Understand that future applications may be affected by medication use Industry Trends to Watch Some forward-thinking insurance companies are exploring partnerships with GLP-1 providers to improve medication adherence
Portsmouth, N.H.: Peter Randall Publisher
There are currently two GLP-1 agonists approved by the FDA for chronic weight management
The weight loss effects observed with GLP-1 receptor agonists led to further investigation of these medications for obesity management in patients without diabetes
Glutathione, Cysteine & C contains 100 gluten-free capsules, enough for up to a 3-month supply
When ipamorelin binds to GHS-R1a, the pituitary releases a pulse of growth hormone
US$ 22.76
US$ 22.61
US$ 27.49
